To include your compound in the COVID-19 Resource Center, submit it here.

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

Constellation raises close to $200M
Cancer epigenetics company Constellation Pharmaceuticals Inc. (NASDAQ:CNST) raised $192.5 million in a bumped-up follow-on Tuesday through the sale of 5.5 million shares at $35. The price is a 7% discount to its

Read the full 364 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers